New cell therapy aims to boost hearing restoration in cochlear implant patients

NCT ID NCT07032038

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 32 times

Summary

This early-stage trial tests a cell therapy called Rincell-1 for adults with certain types of hearing loss who are already getting a cochlear implant. About 20 participants will either receive the implant alone or with an injection of Rincell-1. The main goal is to check safety, but researchers will also look for signs that the therapy helps improve hearing nerve function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORINEURAL HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cambridge University Hospital

    Cambridge, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guy's and St Thomas' Trust

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospitals Birmingham

    Birmingham, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.